Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. (MIPI) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 192 transactions totaling $2.9M, demonstrating a bullish sentiment with $2.4M in net insider flow. The most recent transaction on Jan 28, 2011 involved a sale of 6,000 shares valued at $960.
MIPI Insider Activity Summary
Who Is Buying MIPI Stock?
No significant insider buying has been recorded for MIPI in the recent period.
Who Is Selling MIPI Stock?
No significant insider selling has been recorded for MIPI in the recent period.
Is Molecular Insight Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MIPI is bullish with an Insider Alignment Score of 91/100 and a net flow of $2.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
MIPI Frequently Asked Questions
Understanding MIPI Insider Activity
Insider trading at Molecular Insight Pharmaceuticals, Inc. (MIPI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading MIPI stock, having executed 192 transactions in the past 90 days. The most active insider is James F. Kronauge (Executive), who has made 3 transactions totaling $43.2M.
Related Tools
Track Molecular Insight Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at MIPI file new Form 4 transactions